Allergan Inc., of Irvine, Calif., received a request for additional information under the Hart-Scott-Rodino Act from the U.S. Federal Trade Commission in connection with Laval, Quebec-based Valeant Pharmaceuticals International Inc.'s unsolicited acquisition proposal.